Assessment of hyperkalemia`s illness and treatment burden in Chronic kidney disease and heart failure patients: HK Registry pilot study

Trial Identifier: D9480R00030
Sponsor: AstraZeneca
NCTID:: NCT04466969
Start Date: July 2020
Primary Completion Date: November 2020
Study Completion Date: November 2020
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan, Aichi Nagoyashi, Aichi, Japan, 457-8511
Japan, Chiba Matsudoshi, Chiba, Japan, 271-0077
Japan, Fukuoka Iizukashi, Fukuoka, Japan, 820-8505
Japan, Ibaraki Sashimagun, Ibaraki, Japan, 306-0433
Japan, Ibaraki Tsuchiurashi, Ibaraki, Japan, 300-0028